Frankfurt - Delayed Quote EUR
Vanda Pharmaceuticals Inc. (VM4.F)
3.7800
-0.0800
(-2.07%)
As of 8:04:42 AM GMT+2. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.73M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 5.01 - 5.02 per share. | Direct | 50,150 | Mar 6, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 5.01 - 5.03 per share. | Direct | 50,200 | Mar 5, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 4.70 per share. | Direct | 47,050 | Mar 3, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 4.76 per share. | Direct | 47,600 | Feb 28, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 4.76 per share. | Direct | 47,600 | Feb 27, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 4.75 - 4.78 per share. | Direct | 47,650 | Feb 26, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Purchase at price 4.46 per share. | Direct | 44,640 | Feb 25, 2025 |
| MORAN KEVIN PATRICK Chief Financial Officer | Purchase at price 4.39 per share. | Direct | 8,779 | Feb 21, 2025 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| BIRZNIEKS GUNTHER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| WILLIAMS TIMOTHY IAN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| WIJKSTROM JOAKIM PER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| MORAN KEVIN PATRICK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 18, 2025 |
| MITCHELL STEPHEN RAY Director | Sale at price 5.17 per share. | Direct | 25,863 | Nov 14, 2024 |
| MORAN KEVIN PATRICK Chief Financial Officer | Sale at price 5.92 per share. | Direct | 13,327 | Jul 29, 2024 |
| CHROUSOS PHAEDRA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2024 |
| DUGAN RICHARD W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 17, 2024 |
| WARD ANNE SEMPOWSKI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 17, 2024 |
| MITCHELL STEPHEN RAY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 17, 2024 |
| HONORE TAGE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 17, 2024 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Sale at price 4.13 - 4.24 per share. | Direct | 231,339 | Mar 5, 2024 |
| BIRZNIEKS GUNTHER Officer | Sale at price 4.13 - 4.30 per share. | Direct | 73,379 | Mar 5, 2024 |
| WILLIAMS TIMOTHY IAN General Counsel | Sale at price 4.18 - 4.41 per share. | Direct | 73,313 | Mar 5, 2024 |
| WIJKSTROM JOAKIM PER Officer | Sale at price 4.21 - 4.41 per share. | Direct | 71,921 | Mar 5, 2024 |
| MORAN KEVIN PATRICK Chief Financial Officer | Sale at price 4.20 - 4.48 per share. | Direct | 63,393 | Mar 5, 2024 |
| POLYMEROPOULOS MIHAEL HRISTOS Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 16, 2024 |
| BIRZNIEKS GUNTHER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 16, 2024 |
| WILLIAMS TIMOTHY IAN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 16, 2024 |
| WIJKSTROM JOAKIM PER Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 16, 2024 |
| MORAN KEVIN PATRICK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 16, 2024 |
| WIJKSTROM JOAKIM PER Officer | Sale at price 5.84 per share. | Direct | 21,748 | Aug 21, 2023 |
| MITCHELL STEPHEN RAY Director | Sale at price 6.05 per share. | Direct | 39,349 | Aug 10, 2023 |
| MORAN KEVIN PATRICK Chief Financial Officer | Sale at price 6.30 per share. | Direct | 13,945 | Jul 28, 2023 |
| MORAN KEVIN PATRICK Chief Financial Officer | Sale at price 6.29 per share. | Direct | 100,710 | Jun 15, 2023 |
| WILLIAMS TIMOTHY IAN General Counsel | Sale at price 6.56 per share. | Direct | 95,754 | Jun 13, 2023 |
| DUGAN RICHARD W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
| CHROUSOS PHAEDRA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
| WARD ANNE SEMPOWSKI Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
| MITCHELL STEPHEN RAY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
| HONORE TAGE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 8, 2023 |
Related Tickers
YB4P.SG Savara Inc
2.8000
-1.41%
NVV1.BE Novavax Inc
6.50
+15.66%
OMGAQ Omega Therapeutics, Inc.
0.0470
+42.42%
LVTX LAVA Therapeutics N.V.
1.3600
-1.45%
IMNN Imunon, Inc.
0.8766
+0.53%
INZY Inozyme Pharma, Inc.
0.9806
-4.80%
SVRA Savara Inc.
3.2500
+0.93%
IMRX Immuneering Corporation
1.4100
+2.17%
IMMP Immutep Limited
1.6200
+5.88%
TVRD Tvardi Therapeutics, Inc.
18.48
-5.18%